The recent decision to Roe vs. Wade overthrowing leaves many unanswered questions about fertilization and what real women have about their bodies. A startup, Posterity Health, focuses on a part of the comparison that has long been overlooked. It is a digital male fertility platform that provides personalized advice, educational resources and treatments to help address male fertility needs, and it has just raised $ 6 million in seed funding under Distributed Ventures.
Although there are a number of diagnostic companies that currently offer semen analysis at home, Posterity Health is a virtual center focused on male fertility that provides personal care for every man trying to conceive, said Posterity CEO Health Pam Pure told TechCrunch.
“Infertility testing has traditionally relied on a female-first approach, leaving male infertility largely ignored,” said Barrett Cowan, co-founder and chief medical officer of Posterity Health. “That said, in fact, in half of all cases where couples struggle to conceive, male infertility is a contributing factor.”
Pure co-founded Posterity Health with her husband Cowan, following their careers as a health technology manager and male fertility specialist respectively. With fertility testing traditionally strongly focused on the female component, they realized how subconscious the man was and the general lack of education about men’s important role in the conception process. Pure told TechCrunch one in eight couples struggles to conceiveand in more than 50% of cases a male fertility factor is involved.
The offspring want to continue educating people about the importance of male fertility testing and help people understand that male conditions can be treated and optimized, providing additional treatment options to couples struggling to conceive, according to Pure.
Progeny helps with a male fertility assessment and a treatment plan to optimize sperm quality via its male health platform Male Factor Management, which provides virtual visits, home diagnostics and personal consultations. The new venture’s services include baseline determinations, sperm preservation, semen analysis, pregnancy loss consultations, diagnostic upgrades, vasectomy definitions and gender reassignment care.
The distinguishing feature of Posterity is that it provides the education and engagement incorporated into its digital platform or home diagnostic testing, Pure noted.
The company will use the latest funding to scale to treat male patients across the United States, where the service was introduced in Colorado, Pure said. It also intends to expand its services, expand its team of specialist doctors and establish partnerships, Pure added. It currently provides care in 26 states and has a team of 15 people.
Posterity Health says its team consists of reproductive urologists who work directly with OB / GYNs, fertility centers and fertility benefit managers to bring an integrated home care solution focused solely on male fertility testing and treatment.
“This is a critical time for couples suffering from infertility issues, especially given the recent decision to overthrow Roe vs. Wade, which leaves many unanswered questions about how it will affect the fertility process,” Pure said.
Several digital healthcare executives, including Merative CEO Gerry McCarthy, Amazon’s former senior vice president of Health Solution Laurie McGraw and Don Holzworth, series entrepreneur and chair of the advisory board at the UNC Gilling School of Public Health, also participated in the latest round . The company declined to comment on its valuation.
“Progeny health focuses on the male component of infertility, which has historically been undermined,” says Shawn Ellis, managing partner at Distributed Ventures. “With Posterity Health, couples benefit from a more inclusive, balanced and comprehensive fertility journey, which can speed up the path to pregnancy.”
English
French
Spanish